Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Leukemia ; 36(7): 1806-1817, 2022 07.
Article in English | MEDLINE | ID: mdl-35568768

ABSTRACT

Idelalisib targets PI3Kδ in the BCR pathway generating only a partial response in CLL patients, indicating that the leukemic cells may have evolved escape signals. Indeed, we detected increased activation of AKT accompanied by upregulation of MYC/BCL2 in post-therapy CLL cells from patients treated with idelalisib/ofatumumab. To unravel the mechanism of increased AKT-activation, we studied the impact of idelalisib on a CLL-derived cell line, MEC1, as a model. After an initial inhibition, AKT-activation level was restored in idelalisib-treated MEC1 cells in a time-dependent manner. As BCAP (B-cell adaptor for PI3K) and CD19 recruit PI3Kδ to activate AKT upon BCR-stimulation, we examined if idelalisib-treatment altered PI3Kδ-recruitment. Immunoprecipitation of BCAP/CD19 from idelalisib-treated MEC1 cells showed increased recruitment of PI3Kδ in association with PI3Kß, but not PI3Kα or PI3Kγ and that, targeting both PI3Kδ with PI3Kß inhibited AKT-reactivation. We detected similar, patient-specific recruitment pattern of PI3K-isoforms by BCAP/CD19 in post-idelalisib CLL cells with increased AKT-activation. Interestingly, a stronger inhibitory effect of idelalisib on P-AKT (T308) than S473 was discernible in idelalisib-treated cells despite increased recruitment of PI3Kδ/PI3Kß and accumulation of phosphatidylinositol-3,4,5-triphosphate; which could be attributed to reduced PDK1 activity. Thus, administration of isoform-specific inhibitors may prove more effective strategy for treating CLL patients.


Subject(s)
Leukemia, Lymphocytic, Chronic, B-Cell , Proto-Oncogene Proteins c-akt , Pyruvate Dehydrogenase Acetyl-Transferring Kinase/metabolism , Class I Phosphatidylinositol 3-Kinases , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Purines/pharmacology , Quinazolinones/pharmacology
2.
Blood Cancer J ; 11(5): 93, 2021 05 17.
Article in English | MEDLINE | ID: mdl-34001853

ABSTRACT

Mitochondrial metabolism is the key source for abundant ROS in chronic lymphocytic leukemia (CLL) cells. Here, we detected significantly lower superoxide anion (O2-) levels with increased accumulation of hydrogen peroxide (H2O2) in CLL cells vs. normal B-cells. Further analysis indicated that mitochondrial superoxide dismutase (SOD)2, which converts O2- into H2O2 remained deacetylated in CLL cells due to SIRT3 overexpression resulting its constitutive activation. In addition, catalase expression was also reduced in CLL cells suggesting impairment of H2O2-conversion into water and O2 which may cause H2O2-accumulation. Importantly, we identified two CpG-islands in the catalase promoter and discovered that while the distal CpG-island (-3619 to -3765) remained methylated in both normal B-cells and CLL cells, variable degrees of methylation were discernible in the proximal CpG-island (-174 to -332) only in CLL cells. Finally, treatment of CLL cells with a demethylating agent increased catalase mRNA levels. Functionally, ROS accumulation in CLL cells activated the AXL survival axis while upregulated SIRT3, suggesting that CLL cells rapidly remove highly reactive O2- to avoid its cytotoxic effect but maintain increased H2O2-level to promote cell survival. Therefore, abrogation of aberrantly activated cell survival pathways using antioxidants can be an effective intervention in CLL therapy in combination with conventional agents.


Subject(s)
Catalase/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , Proto-Oncogene Proteins/metabolism , Reactive Oxygen Species/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Signal Transduction , Sirtuin 3/genetics , Adult , Aged , Aged, 80 and over , Catalase/metabolism , Female , Gene Expression Regulation, Leukemic , Gene Silencing , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/metabolism , Male , Middle Aged , Sirtuin 3/metabolism , Tumor Cells, Cultured , Up-Regulation , Axl Receptor Tyrosine Kinase
3.
Int J Mol Sci ; 22(2)2021 Jan 07.
Article in English | MEDLINE | ID: mdl-33430325

ABSTRACT

Heat stress (HS) is a major abiotic stress that negatively impacts crop yields across the globe. Plants respond to elevated temperatures by changing gene expression, mediated by transcription factors (TFs) functioning to enhance HS tolerance. The involvement of Group I bZIP TFs in the heat stress response (HSR) is not known. In this study, bZIP18 and bZIP52 were investigated for their possible role in the HSR. Localization experiments revealed their nuclear accumulation following heat stress, which was found to be triggered by dephosphorylation. Both TFs were found to possess two motifs containing serine residues that are candidates for phosphorylation. These motifs are recognized by 14-3-3 proteins, and bZIP18 and bZIP52 were found to bind 14-3-3 ε, the interaction of which sequesters them to the cytoplasm. Mutation of both residues abolished 14-3-3 ε interaction and led to a strict nuclear localization for both TFs. RNA-seq analysis revealed coordinated downregulation of several metabolic pathways including energy metabolism and translation, and upregulation of numerous lncRNAs in particular. These results support the idea that bZIP18 and bZIP52 are sequestered to the cytoplasm under control conditions, and that heat stress leads to their re-localization to nuclei, where they jointly regulate gene expression.


Subject(s)
14-3-3 Proteins/genetics , Arabidopsis/genetics , Heat-Shock Response/genetics , RNA, Long Noncoding/genetics , Arabidopsis/growth & development , Arabidopsis Proteins/genetics , Cell Nucleus/genetics , Gene Expression Regulation, Plant/genetics , Transcription Factors/genetics
4.
AMB Express ; 10(1): 173, 2020 Sep 29.
Article in English | MEDLINE | ID: mdl-32990767

ABSTRACT

A novel IDA-LaNDT derivative was able to reach the highest productivity in the biosynthesis of a well-known antitumoral agent called decitabine. However, the combination of two simple and inexpensive techniques such as ionic absorption and gel entrapment with the incorporation of a bionanocomposite such as bentonite significantly improved the stability of this biocatalyst. These modifications allowed the enhancement of storage stability (for at least 18 months), reusability (400 h of successive batches without significant loss of its initial activity), and thermal and solvent stability with respect to the non-entrapped derivative. Moreover, reaction conditions were optimized by increasing the solubility of 5-aza by dilution with dimethylsulfoxide. Therefore, a scale-up of the bioprocess was assayed using the developed biocatalyst, obtaining 221 mg/L·h of DAC. Finally, green parameters were calculated using the nanostabilized biocatalyst, whose results indicated that it was able to biosynthesize DAC by a smooth, cheap, and environmentally friendly methodology.

5.
Oncotarget ; 11(22): 2037-2046, 2020 Jun 02.
Article in English | MEDLINE | ID: mdl-32547702

ABSTRACT

Chronic lymphocytic leukemia (CLL) is still an incurable disease despite aggressive chemotherapies including the B-cell receptor (BCR) targeted-inhibitors. Therefore, we assessed the expression status of key signal mediators of the BCR pathway in CLL cells. Indeed, we detected aberrantly elevated levels of CD79a, B-cell adaptor for PI3K (BCAP) and phospholipase C (PLC)γ2, key mediators of BCR signal, in CLL cells. As HSP90 is also overexpressed in CLL cells, we hypothesized that HSP90 could potentiate the BCR signal via stabilization of multiple key components of the BCR-signalosome. We found that HSP90 formed a multi-molecular complex with CD79a, BCAP, PLCγ2, LYN, SYK, Bruton tyrosine kinase (BTK) and AKT and that, pharmacologic inhibition or partial depletion of HSP90 reduced the expression of these signal mediators in CLL cells. In addition, our findings also demonstrated that HSP90 could stabilize the tyrosine phosphatase, PTPN22 which positively regulates AKT phosphorylation, and the constitutively active fibroblast growth factor receptor 3 (FGFR3) in CLL cells. Finally, HSP90 inhibition induced apoptosis in CLL cells in a dose-dependent manner likely via downregulation of anti-apoptotic proteins MCL-1 and XIAP, but not BCL2, reported to be overexpressed in CLL cells. In total, our findings suggest that HSP90-inhibition may sensitize the leukemic B-cells to BCR-targeted agents, particularly those become resistant to these therapies.

6.
Plant Sci ; 292: 110392, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32005397

ABSTRACT

Furanocoumarins are defense molecules mainly described in four plant families that are phylogenetically distant. Molecular characterization of the biosynthetic pathway has been started for many years in Apiaceae and Rutaceae. The results obtained thus far in Apiaceae indicated a major role of cytochromes P450 (P450s) in the CYP71 family. In the present work, we describe the importance of another subfamily of P450s, CYP82D, identified by using a deep analysis of the citrus (Rutaceae) genome and microarray database. CYP82D64 is able to hydroxylate xanthotoxin to generate 5-OH-xanthotoxin. Minor and limited amino acid changes in the CYP82D64 coding sequence between Citrus paradisi and Citrus hystrix provide the enzyme in the latter with the ability to hydroxylate herniarin, but with low efficiency. The kinetic constants of the enzyme are consistent with those of other enzymes of this type in plants and indicate that it may be the physiological substrate. The activity of the enzyme is identical to that of CYP71AZ6 identified in parsnip, showing possible evolutionary convergence between these two families of plants. It is highly possible that these molecules are derived from the synthesis of ubiquitous coumarins throughout the plant kingdom.


Subject(s)
Citrus/genetics , Cytochrome P-450 Enzyme System/genetics , Evolution, Molecular , Furocoumarins/chemistry , Plant Proteins/genetics , Amino Acid Sequence , Citrus/chemistry , Cytochrome P-450 Enzyme System/chemistry , Cytochrome P-450 Enzyme System/metabolism , Furocoumarins/genetics , Phylogeny , Plant Proteins/chemistry , Plant Proteins/metabolism
7.
Rev Fac Cien Med Univ Nac Cordoba ; 76(2): 86-91, 2019 06 19.
Article in Spanish | MEDLINE | ID: mdl-31216162

ABSTRACT

Introduction: Bisphenol A (BPA) is an endocrine disruptor (ED) possibly linked to adverse reproductive and neurodevelopmental effects that is used as an additive in food and beverage containers. There are no data of BPA levels in the Argentine population. The objective of this study was to measure BPA in the urine of pregnant women. Methods: Cross-sectional study. Detection of BPA in pregnant women of the Hospital Italiano de Buenos Aires in 2013, using gas chromatography and mass spectrometry with a limit of quantification of 2 ng / ml and detection of 0.8 ng / ml. The proportion of women exposed to BPA within the 95% confidence interval (IC 95%) is described. Results: 149 pregnant women, average age 32 years (Standard Deviation 5.3), 81% (95% CI 73.9-86.9) workers and 83.7% (95% CI 76.7-89.1) have university or higher education, 66.4% (95% CI 58-74.0) of the urinary samples were quantifiable, with a median BPA of 4.3 ng/mg Cr (RI 3.2-6.7). Conclusions: This study shows that exposure to BPA during the process of embryonic development in a sector of the population of Argentina is widespread. In Argentina, the use of this ED is only regulated in baby bottles.


Introducción: El Bisfenol A (BPA) es un disruptor endócrino (DE) posiblemente vinculado a eventos adversos reproductivos y del desarrollo neurológico que se utiliza como aditivo en envases plásticos de alimentos y bebidas. En la población argentina no existen datos sobre niveles de BPA en orina. El objetivo del estudio fue medir la presencia de BPA en orina de embarazadas. Métodos: Estudio transversal. Detección de BPA en orina de embarazadas atendidas en el Hospital Italiano de Buenos Aires en el año 2013. La técnica utilizada fue cromatografía gaseosa asociada a espectrometría de masa con un límite de cuantificación de 2 ng/ml y de detección de 0,8 ng/ml. Se describe la proporción de mujeres con exposición al BPA con su intervalo de confianza del 95% (IC95%). Resultados: se analizaron 149 muestras de orina de embarazadas de edad promedio 32 años (Desvío Standard 5,3), el 81% (IC95% 73,9-86,9) trabaja y el 83,7% (IC95% 76,7-89,1) posee nivel universitario y/o posgrado.El 66,4% (IC95% 58,2-74,0) de las muestras urinarias presentaron BPA cuantificable, siendo la mediana de BPA de 4,3 ng / mg creatinina (Rango Intercuartilo 3,2-6,7). Conclusiones: Este estudio muestra que la exposición a BPA durante el proceso de formación embrionaria en un sector de la población de Argentina, es generalizada. En Argentina solo está regulado el uso de este DE en mamaderas.


Subject(s)
Benzhydryl Compounds/urine , Endocrine Disruptors/urine , Maternal Exposure/statistics & numerical data , Phenols/urine , Adolescent , Argentina , Cross-Sectional Studies , Female , Humans , Pregnancy
8.
Ginecol. obstet. Méx ; 87(5): 319-323, ene. 2019. graf
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1286623

ABSTRACT

Resumen ANTECEDENTES: Las arritmias cardiacas son complicaciones frecuentes durante el embarazo, la mayor parte son benignas y no requieren tratamiento complejo. Las taquicardias ventriculares idiopáticas suelen ser hemodinámicamente estables y se asocian con buen pronóstico. CASO CLÍNICO: Paciente de 22 años, con embarazo de 23 semanas, que inició con mareo y palpitaciones, por lo que acudió al servicio de Urgencias. El electrocardiograma de 12 derivaciones mostró una taquicardia de QRS amplio, con latidos de fusión y disociación auriculoventricular; el ecocardiograma no reportó alteraciones. El diagnóstico definitivo fue taquicardia ventricular fascicular posterior idiopática. El tratamiento inicial consistió en verapamil y amiodarona por 48 horas; sin embargo, persistió la taquicardia, por lo que se decidió realizar una cardioversión eléctrica con 200 Joules, con lo que se obtuvo una reacción satisfactoria. La paciente permaneció asintomática hasta la semana 31 del embarazo, cuando inició nuevamente con palpitaciones; se documentó la misma taquicardia, por lo que se decidió realizar un nuevo procedimiento de cardioversión eléctrica con 200 Joules, que resultó efectiva y sin complicaciones adicionales para la paciente. CONCLUSIONES: La incidencia de taquicardia ventricular idiopática durante el embarazo es relativamente baja. La cardioversión eléctrica es una opción efectiva en pacientes embarazadas con resistencia al tratamiento farmacológico o inestabilidad hemodinámica.


Abstract BACKGROUND: Cardiac arrhythmias are frequent complications in pregnancy, the most of them are benign and don't need specific treatment. Idiopathic ventricular tachycardia usually is hemodynamically stable and associate with a good prognosis. CLINICAL CASE: A 22-year-old woman with a current pregnancy of 23.4 weeks of gestation that began with dizziness and palpitations, she went to the emergency department, a 12-lead electrocardiogram showed a wide QRS tachycardia with fusion beats and atrioventricular dissociation, the echocardiogram was reported normal. Posterior fascicular ventricular idiopathic tachycardia was concluded. Initially, Verapamil and Amiodarone were administered for 48 hours, with tachycardia persisting, so it was decided to perform electrical cardioversion with 200 Joules that was effective. She remained asymptomatic until the 31st week of gestation where she started again with palpitations, the same tachycardia was documented and it was decided to perform again electrical cardioversion with 200 joules, being effective and without complications. CONCLUSIONS: Idiopathic ventricular tachycardia occurs with low frequency in pregnancy. When pharmacological therapy is not effective or there is hemodynamic instability, electrical cardioversion is a viable option in the pregnant patient.

9.
Acta bioquím. clín. latinoam ; 52(1): 79-87, mar. 2018. graf, tab
Article in Spanish | LILACS | ID: biblio-886165

ABSTRACT

El Bisfenol-A (BPA) es ampliamente utilizado en la producción de plásticos de policarbonato, por lo que está presente en productos de uso masivo. Es un disruptor endócrino e incide en el desarrollo gonadal y del sistema nervioso central. La exposición de mujeres embarazadas al BPA es particularmente preocupante para el feto en desarrollo, debido a que atraviesa la placenta pasando a la sangre de cordón y al líquido amniótico. Esto se suma a la escasa o nula actividad enzimática fetal para biotransformarlo en BPA-glucurónido inactivo, causando posibles efectos nocivos a la descendencia a dosis muy bajas y sostenidas. Con el propósito de estudiar la exposición al BPA y sus efectos en la población de Argentina se desarrolló y validó un método analítico por cromatografía líquida acoplada a espectrometría de masa, que permite la cuantificación de trazas de BPA libre (forma estrogénica, activa) en plasma de cordón umbilical. La técnica consiste en la precipitación de proteínas de la sangre de cordón por agregado de acetonitrilo y posterior centrifugado e inyección del sobrenadante. Se utilizó una elución isocrática en la cromatografía líquida, y la espectrometría de masa se realizó empleando Electrospray negativo en modo de monitoreo de reacciones múltiples. Los valores de BPA libre cuantificados están en el rango de 1,0 a 12,1 ng/mL, límite de detección: 0,6 ng/mL.


Bisphenol-A (BPA) is widely used in the production of polycarbonate plastics and therefore, it is present in products of massive use. It is known as an endocrine disruptor and has an impact on gonadal and central nervous system development. Exposure of pregnant women to BPA is particularly worrying for the developing fetus because it crosses the placenta into the cord blood and amniotic fluid, coupled with little or no fetal enzymatic activity to biotransform it into inactive BPA-glucuronide, causing possible harmful effects to the offspring at very low and sustained doses. With the aim to study the exposure to BPA and its effects on the population of Argentina, an analytical method was developed and validated by liquid chromatography coupled to mass spectrometry, which allows the quantification of trace amounts of free BPA (estrogenic, active form) in plasma of umbilical cord. The method involves protein precipitation by the addition of acetonitrile and subsequent centrifugation and injection of supernatant. An isocratic elution was used in liquid chromatography, and mass spectrometry was performed using negative Electrospray mode in multiple reaction monitoring. Quantified free BPA values are in the range of 1.0 to 12.1 ng/mL, Detection Limit: 0,6 ng/mL.


O Bisfenol-A (BPA) é amplamente utilizado na produção de plásticos de policarbonato, portanto está presente em produtos de uso massiço. Ele é um disruptor endócrino e tem um impacto no desenvolvimento gonadal e do sistema nervoso central. A exposição de mulheres grávidas ao BPA é particularmente preocupante para o feto em desenvolvimento, visto que atravessa a placenta passando ao sangue do cordão e ao líquido amniótico Isso é adicionado à pouca ou nula atividade enzimática fetal para biotransformá-lo em BPA-glicuronídeo inativo, o que causa possíveis efeitos nocivos aos descendentes em doses muito baixas e sustentadas. Visando a estudar a exposição ao BPA e seus efeitos na população da Argentina, foi desenvolvido e validado um método analítico por cromatografia líquida acoplada à espectrometria de massa, que permitem a quantificação de vestígios de BPA livre (forma estrogênica, livre) em plasma do cordão umbilical. A técnica consiste na precipitação de proteínas do sangue de cordão por adição de acetonitrila e posterior centrifugação e injeção no sobrenadante. Na cromatografia líquida, foi utilizada uma eluição isocrática, e a espectrometria de massa foi realizada utilizando Electrospray negativo em modo de monitoramento de reações múltiplas. Os valores de BPA livre quantificados estão na faixa de 1,0 a 12,1 ng/mL, limite de detecção: 0,6 ng/mL.


Subject(s)
Humans , Chromatography, Liquid , Endocrine Disruptors , Fetal Blood , Mass Spectrometry , Diet , Evaluation Studies as Topic
10.
Ther Drug Monit ; 40(2): 276-283, 2018 04.
Article in English | MEDLINE | ID: mdl-29432386

ABSTRACT

BACKGROUND: Voriconazole is a broad-spectrum triazole antifungal agent. It is widely used in the treatment of invasive fungal infections in immunocompromised patients. Because the pharmacokinetics of voriconazole demonstrates considerable variability, monitoring its serum levels plays an important role in optimizing therapies against many clinically relevant fungal pathogens. The aim of this study was to validate a simple and rapid U-HPLC-PDA method with minimal sample preparation for routine therapeutic drug monitoring (TDM) of voriconazole. METHODS: After protein precipitation with the internal standard solution (posaconazole 5.0 mg/L in acetonitrile), chromatographic separation was performed in 4 minutes using water and acetonitrile as mobile phases and an Acquity UPLC BEH HSS C18 column (2.1 × 100 mm, 1.7 µm). The temperature was set at 45°C and the flow rate was 0.4 mL/min. Photodiode array detection at 256 nm was used as detection system. The method was validated according international guidelines for linearity, accuracy, precision, selectivity, lower limit of quantitation, carry over, and stability under different conditions. RESULTS: All performance parameters were within acceptance criteria, demonstrating that the validated method is fit for purpose. After assay validation, 115 serum samples collected from 41 patients were analyzed to report the experience of the laboratory in TDM of voriconazole. Results showed a large variability in voriconazole trough levels, suggesting that this drug should be frequently measured in patients under treatment to enhance therapies efficacy and improve safety. CONCLUSIONS: In this study, a reproducible U-HPLC-PDA assay with a short analysis time, requiring only a small amount of serum, good accuracy and reproducibility was validated, which is suitable for routine TDM of voriconazole in serum.


Subject(s)
Chromatography, High Pressure Liquid/methods , Chromatography, Reverse-Phase/methods , Voriconazole/blood , Adolescent , Adult , Aged , Child , Child, Preschool , Drug Monitoring/methods , Female , Humans , Infant , Male , Middle Aged , Reproducibility of Results , Young Adult
11.
J Biotechnol ; 270: 39-43, 2018 Mar 20.
Article in English | MEDLINE | ID: mdl-29355814

ABSTRACT

The 2'-N-deoxyribosyltransferases [NDT; EC 2.4.2.6] are a group of enzymes widely used as biocatalysts for nucleoside biosynthesis. In this work, the molecular cloning, expression and purification of a novel NDT from Lactobacillus animalis (LaNDT) have been reported. On the other hand, biocatalyst stability has been significantly enhanced by multipoint covalent immobilization using a hetero-functional support activated with nickel-chelates and glyoxyl groups. The immobilized enzyme could be reused for more than 300 h and stored during almost 3 months without activity loss. Besides, the obtained derivative (Ni2+-Gx-LaNDT) was able to biosynthesize 88 mg floxuridine/g biocatalyst after 1 h of reaction. In this work, a green bioprocess by employing an environmentally friendly methodology was developed, which allowed the obtaining of a compound with proven anti-tumor activity. Therefore, the obtained enzymatic biocatalyst meets the requirements of high activity, stability, and short reaction times needed for low-cost production in a future preparative application.


Subject(s)
Cloning, Molecular/drug effects , Enzymes, Immobilized/metabolism , Lactobacillus/enzymology , Transferases/metabolism , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Biocatalysis , Enzyme Stability , Enzymes, Immobilized/chemistry , Enzymes, Immobilized/genetics , Lactobacillus/chemistry , Models, Molecular , Protein Conformation , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Transferases/chemistry , Transferases/genetics
12.
Int J Clin Pharmacol Ther ; 54(10): 825-34, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27049055

ABSTRACT

OBJECTIVE: To evaluate the relative bioavailability of a new formulation of emtricitabine (EMT) 200 mg and tenofovir disoproxil fumarate (TNF) 300 mg and to compare with reference formulation to meet regulatory criteria in Argentina. METHODS: A randomized-sequence, open-label, twoperiod crossover study was conducted on 24 healthy Caucasian volunteers in a fasting state. A single oral dose of T or R formulations was followed by a 7-day washout period. Samples were collected at baseline, 0.25, 0.50, 0.75, 1, 1.25, 1.5, 2, 2.5, 3, 4, 7, 12, 24, and 48 hours after administration. EMT and TNF were determined by LC-MS/MS. RESULTS: Geometric means (90% CI) Cmax for EMT in test and reference were 1,891.22 (1,777.1 - 2,187.31) and 1,830.31 (1,721.19 - 2,134.01) ng/mL, the AUC0-t were 10,283.07 (9,624.29 - 11,566.34) and 10,518.76 (9,942.79 - 11,578.30) ng × h/mL and the AUC0-∞ were 10,615.14 (9,948.56 - 11,866.26) and 10,804.12 (10,221.04 - 11,864.85) ng × h/mL, respectively. For TNF test and reference, Cmax geometric means (CI range) were 202.91 (187.91 - 255.78) and 212.04 (195.98 - 264.87) ng/mL, AUC0-t were 1,429.96 (1,334.63 - 1,680.00) and 1,420.75 (1,326.76 - 1,622.18) ng × h/mL and AUC0-∞ were 1,657.11 (1,551.60 - 1,921.75) and 1,631.84 (1,523.95 - 1,857.97), respectively. No differences were detected between the formulations. The test/reference ratios (90% CI) for Cmax, AUC0-t, and AUC0-∞ were 103.33% (95.7 - 111.6), 97.76% (93.6 - 102.1), and 98.25% (94.3 - 102.4) for EMT, and 95.70% (85.9 - 106.6), 95.20% (83.4 - 108.6) and 91.10% (80.7 - 102.7) for TNF. CONCLUSIONS: In this single-dose study, the EMT/TNF tablets (test formulation) met the standard 90% CI criterion for bioequivalence with the reference formulation.


Subject(s)
Anti-HIV Agents/administration & dosage , Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/administration & dosage , Adult , Anti-HIV Agents/pharmacokinetics , Area Under Curve , Argentina , Biological Availability , Chromatography, Liquid , Cross-Over Studies , Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/pharmacokinetics , Female , Humans , Male , Middle Aged , Tablets , Tandem Mass Spectrometry , Therapeutic Equivalency , Time Factors , Young Adult
13.
GEN ; 61(2): 132-135, jun. 2007. ilus, tab
Article in Spanish | LILACS | ID: lil-664269

ABSTRACT

Introducción: en los modelos murinos de inflamación intestinal, de una manera similar a lo que sucede en el hombre, los macrófagos activados producen una potente mezcla de citocinas inflamatorias que influyen al factor de necrosis tumoral alfa (TNF-α). El TNF-α, aumenta el proceso inflamatorio y la destrucción tisular, lo que se manifiesta en la sintomatología de la enfermedad. Los antiinflamatorios no esteroideos (AINES) inhiben la producción de prostaglandinas y han sido reconocidos como inhibidores de la producción del TNF-α. En este estudio, se relaciona la inhibición de las prostaglandinas utilizando el celecoxib con los niveles de TNF-α en ratas con inflamación intestinal y se compara con ratas inflamadas no tratadas. Métodos: se determinaron los niveles de TNF-α en ratas con colitis inducida por ácido acético. El grupo control estuvo representado por 4 ratas instiladas con agua destilada, un grupo de 7 ratas inflamadas sin tratamiento y tres grupos de 7 ratas cada uno medicadas con diferentes concentraciones de celecoxib. Al tercer día se sacrificaron las ratas. A todas se les tomo sangre antes de inflamarlas y de sacrificarlas. Se tomaron muestras de colón para estudio histológico. Los niveles de TNF-α se determinaron por ELISA. Resultados: el edema, la erosión y ulceración es menor en las ratas tratadas que en las inflamadas no tratadas. Los niveles TNF-α obtenidos en los grupos tratados fueron significativamente menores cuando se comparan con el grupo no tratado. Conclusiones: las ratas tratadas con inhibidor de la COX-2 tienen niveles menores de TNF-α y menores lesiones de la mucosa colónica, por lo que podría convertirse en un arma terapéutica importante para la enfermedad inflamatoria intestinal.


Introduction: In murine models of bowel inflammation, in a similar way that occurs in humans, activated macrophages produce a powerful mixture of inflammatory ciytokines that influence the tumor necrosis factor alpha (TNF-α). The TNF-α, increases the inflammatory process and tissue destruction, producing the symptoms of the disease. Non steroidal antiinflamatory drugs (NSAID's) inhibit the production of prostaglandins and have been recognized as inhibitors of the TNF-α production. In this study we correlate prostaglandin inhibition using Celecoxib with TNF-α levels in rats with bowel inflammation comparing results with non treated rats. Methods: The TNF-α levels were determined in rats with induced colitis with acetic acid. The control group was represented by 4 rats administered with distilled water, a group of 7 rats without treatment and three groups of 7 medicated rats each one with different Celecoxib concentrations. At the third day the rats were sacrificed. All rats had blood samples taken before inducing colitis, and after being sacrificed. Histological samples were taken from the colon for pathological study. TNF-α levels were determined by ELISA. Results: Edema, erosion and ulceration were less in the treated rats that in the non treated. TNF-α levels in the treated group were significantly lower when compared with the non treated group. Conclusions: Rats treated with COX-2 inhibitor have lower TNF-α levels and minor injuries to the colonic mucosa, for these reasons it could develop into an important therapeutic weapon for inflammatory bowel disease.

14.
Rev. méd. Costa Rica Centroam ; 71(566): 41-43, ene.-mar. 2004. ilus
Article in Spanish | LILACS | ID: lil-400970

ABSTRACT

El Lorazepan es una benzodiazepina ampliamente utilizada con fines ansiolíticos, sedacción, hipnosis, efectos anticonvulsivantes y miorrelajación central. Para este estudio se eligió una muestra de 41 expedientes al azar del total de pacientes que recibieron lorazepam en el mes de febrero del 2003 en la Clínica Central de Atenas, de lo cual se extrajo que una mayoría (73 por ciento) corresponden a mujeres, un 29 por ciento iniciaron el consumo antes de los 40 años, y la mayoría tienen entre 16 y 20 años de consumo.


Subject(s)
Humans , Adult , Female , Lorazepam , Costa Rica
15.
Rev. méd. Costa Rica Centroam ; 71(566): 45-46, ene.-mar. 2004.
Article in Spanish | LILACS | ID: lil-400971

ABSTRACT

El presente caso, es de una paciente quien se le diagnóstico bocio multinodular a los 47 años el cual fue tratado con levotiroxina por 10 años y finalmente fue operado con diagnóstico postoperatorio de bocio multinodular intratorácico. Actualmente el uso de levotiroxina para el tratamiento del bocio multinodular es cuestionado por el riesgo de autonomía de alguno de los nódulos, esta es una de las razones por los que la tiroidectomía total se ha convertido en la opción preferida tanto para bocio multinodular como para bocio intratorácico.


Subject(s)
Humans , Female , Middle Aged , Goiter , Goiter, Nodular , Thyroxine/administration & dosage , Thyroxine/adverse effects , Thyroxine/therapeutic use , Costa Rica
18.
Rev. méd. Costa Rica Centroam ; 70(565): 159-161, oct.-dic. 2003. ilus
Article in Spanish | LILACS | ID: lil-359462

ABSTRACT

Las infecciones del tracto urinario son la principal causa de morbilidad actualmente, por lo cual a su vez implican el mayor gasto en salud en personas de todas las edades. Nuestro estudio comprendió urocultilvos realizados en la clínica de Atenas del 5-8-02 al 17-12-03, de los cuales; un 78.43 por ciento fueron positivos para E. coli relegando a los demás agentes a una minoría, además la mayoría de las cepas de E. coli son resistentes al Trimetoprim sulfametoxazole (TMP SMX) que es actualmente el medicamento más utilizado. Como segundo agente causal más frecuente encontramos a Kliebsiella sp.


Subject(s)
Humans , Urinary Tract , Escherichia coli Infections , Trimethoprim, Sulfamethoxazole Drug Combination/administration & dosage , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Urologic Diseases/diagnosis , Urologic Diseases/etiology , Urologic Diseases/drug therapy , Urologic Diseases/therapy , Costa Rica
SELECTION OF CITATIONS
SEARCH DETAIL
...